{"title":"Helicobacter pylori 除菌後の体重増加","authors":"弘之 須藤, 義幸 伊藤, 幸直 山崎, 卓次 加藤","doi":"10.11405/NISSHOSHI.104.339","DOIUrl":null,"url":null,"abstract":"Helicobacter pylori (H pylori) is a common bacterium that is present in millions of people worldwide. In the United States, more than 50% of people older than 60 years are affected. Helicobacter pylori is found in the mucous lining of the stomach. It is known to be responsible for 60% to 80% of gastric ulcers (those occurring in the stomach) and 70% to 90% of duodenal ulcers (those occurring in the first part of the small intestine). The recognition of an association between this bacterium and peptic ulcer disease (occurring in the stomach or duodenum) by Dr Barry J. Marshall and Dr John R. Warren, both from Australia, was made in 1983, and they were awarded the Nobel prize in physiology (how the body works internally) and medicine in 2005. It is now understood that peptic ulcer disease is not caused by stress or by eating foods high in acid. It is often caused by the H pylori bacterium. Although the infection typically is acquired in childhood, it may continue without any problem throughout a person’s lifetime. Only 15% to 20% of those who carry this bacterium ever develop symptoms related to an ulcer. Treatment is recommended only for people who have an ulcer as a consequence of the bacterium’s presence. Treatment is important because people who have ulcers tend to have recurrent problems, and eliminating the H pylori infection prevents relapses. Patients infected with H pylori are more likely than others to develop certain types of cancer of the stomach, so testing and treatment for H pylori infection is recommended in patients with a family history of gastric cancer. This issue of JAMA includes a Commentary about a new treatment option for H pylori.","PeriodicalId":341053,"journal":{"name":"The Japanese journal of gastro-enterology","volume":"5 12 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2007-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Japanese journal of gastro-enterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11405/NISSHOSHI.104.339","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Helicobacter pylori (H pylori) is a common bacterium that is present in millions of people worldwide. In the United States, more than 50% of people older than 60 years are affected. Helicobacter pylori is found in the mucous lining of the stomach. It is known to be responsible for 60% to 80% of gastric ulcers (those occurring in the stomach) and 70% to 90% of duodenal ulcers (those occurring in the first part of the small intestine). The recognition of an association between this bacterium and peptic ulcer disease (occurring in the stomach or duodenum) by Dr Barry J. Marshall and Dr John R. Warren, both from Australia, was made in 1983, and they were awarded the Nobel prize in physiology (how the body works internally) and medicine in 2005. It is now understood that peptic ulcer disease is not caused by stress or by eating foods high in acid. It is often caused by the H pylori bacterium. Although the infection typically is acquired in childhood, it may continue without any problem throughout a person’s lifetime. Only 15% to 20% of those who carry this bacterium ever develop symptoms related to an ulcer. Treatment is recommended only for people who have an ulcer as a consequence of the bacterium’s presence. Treatment is important because people who have ulcers tend to have recurrent problems, and eliminating the H pylori infection prevents relapses. Patients infected with H pylori are more likely than others to develop certain types of cancer of the stomach, so testing and treatment for H pylori infection is recommended in patients with a family history of gastric cancer. This issue of JAMA includes a Commentary about a new treatment option for H pylori.
幽门螺杆菌(幽门螺杆菌)是一种常见的细菌,存在于全球数百万人体内。在美国,超过50%的60岁以上的老年人受到影响。幽门螺杆菌存在于胃粘膜中。已知60%至80%的胃溃疡(发生在胃里的溃疡)和70%至90%的十二指肠溃疡(发生在小肠的前半部分)是由它引起的。1983年,澳大利亚的巴里·j·马歇尔(Barry J. Marshall)博士和约翰·r·沃伦(John R. Warren)博士发现了这种细菌与消化性溃疡(发生在胃或十二指肠)之间的联系,并于2005年获得了诺贝尔生理学(人体内部如何运作)和医学奖。现在了解到消化性溃疡疾病不是由压力或食用高酸食物引起的。它通常由幽门螺杆菌引起。虽然这种感染通常是在儿童时期获得的,但它也可能在一个人的一生中毫无问题地持续下去。只有15%到20%的携带这种细菌的人会出现与溃疡有关的症状。建议只对因细菌存在而导致溃疡的人进行治疗。治疗很重要,因为患有溃疡的人往往有复发的问题,消除幽门螺杆菌感染可以防止复发。感染幽门螺杆菌的患者比其他人更容易患上某些类型的胃癌,因此建议有胃癌家族史的患者进行幽门螺杆菌感染的检测和治疗。本期《美国医学会杂志》包括一篇关于幽门螺杆菌新治疗方案的评论。